Clinical Trials Directory

Trials / Terminated

TerminatedNCT01459861

Early Ambulation After Adductor Canal Block for Total Knee Arthroplasty

Assessment of Early Ambulation in Patients Receiving Continuous Adductor Canal Block With Ultrasound Guided Posterior Capsular Knee Injection vs. Femoral Nerve Block With Tibial Nerve Block Following Total Knee Replacement

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Trinity Health Of New England · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess early ambulation following total knee replacement in patients receiving continuous adductor canal block with posterior capsular injection compared to continuous femoral nerve block with tibial nerve block.

Conditions

Interventions

TypeNameDescription
PROCEDURECanal Block and Capsular InjectionContinuous Adductor canal block with 15ml of ropivacaine 0.2% with epinephrine 1:400,000 followed by an infusion of ropivacaine 0.2% at 6ml per hour for 2 days post operatively. This is combined with ultrasound guided posterior capsular knee injection with 30ml ropivacaine 0.2% with epinephrine 1:400,000.
PROCEDUREFemoral Nerve Block with Tibial Nerve BlockContinuous femoral nerve block with 15ml of ropivacaine 0.2% followed by an infusion of ropivacaine 0.2% at 6ml per hour for 2 days after surgery combined with tibial nerve block in the popliteal fossa with ropivacaine 0.5% up to 15ml.

Timeline

Start date
2011-10-01
Primary completion
2012-09-01
Completion
2012-09-01
First posted
2011-10-26
Last updated
2013-03-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01459861. Inclusion in this directory is not an endorsement.